Characterization and pharmacological relevance of high affinity binding sites for [3H]LY186126, a cardiotonic phosphodiesterase inhibitor, in canine cardiac membranes.

Kauffman, R F

Characterization and pharmacological relevance of high affinity binding sites for [3H]LY186126, a cardiotonic phosphodiesterase inhibitor, in canine cardiac membranes. [electronic resource] - Circulation research Jul 1989 - 154-63 p. digital

Publication Type: Journal Article

0009-7330

10.1161/01.res.65.1.154 doi


3',5'-Cyclic-AMP Phosphodiesterases--metabolism
Animals
Binding Sites
Cardiotonic Agents--metabolism
Cyclic GMP--metabolism
Dogs
Enzyme Activation--drug effects
Hydrogen-Ion Concentration
Indoles--metabolism
Ions
Membranes--metabolism
Myocardium--metabolism
Oxindoles
Phosphodiesterase Inhibitors--metabolism
Pyridazines--metabolism
Sarcoplasmic Reticulum--metabolism